A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Neeta SomaiahBrian Andrew Van TineAmy E WahlquistMohammed M MilhemElizabeth G HillElizabeth Garrett-MayerKent E ArmesonScott M SchuetzeChristian F MeyerDaniel Y ReubenAnthony D EliasWilliam L ReadSant P ChawlaAndrew S KraftPublished in: Cancer (2020)
The data from the current study have demonstrated the safety and efficacy of G+P as an alternative to G+T for patients with nonadipocytic STS.